Pinealon
Brain & nervous system Research only Human trials Synthetic short peptide (Cytogen)
Also called EDR peptide, T-33
A three-amino-acid Khavinson peptide associated with brain tissue. Studies report that it protects neurons from low-oxygen and oxidative stress and may influence memory, learning and sleep-wake rhythm.
Evidence at a glance
- Evidence
- Human trials — Studied in people
- Status
- Research compound only
- Dosing
- No human study has set a dose
Animal data plus small Russian human studies.
What studies report
- Protected neurons from low-oxygen and oxidative stress in animals
- Reported effects on memory, learning and sleep-wake rhythm
How it works
A Khavinson short peptide: at two to four amino acids it is small enough to pass through cell and nuclear membranes intact. The proposed mechanism is that it binds specific sites on nuclear DNA and changes which genes are switched on in its target tissue, rather than acting on a surface receptor the way most peptides do.
Where it acts
BrainThe library groups this compound under Brain & nervous system. The diagram shows that target, not every tissue it reaches.
Illustrated
AI-generated subject illustration; not a depiction of the compound or evidence of its effects.
Why people take it
Reasons people seek it out — not a list of proven effects.
Status: Animal and cell data, plus small Russian human studies.
- Route
- Subcutaneous injection, or oral capsule depending on the preparation
- Sequence
- Glu-Asp-Arg
- Formula
- C15H26N6O8
- Molecular weight
- 418.4 g/mol
- Available as
- 20 mg
Search PubMed for Pinealon → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.